Indication
Demyelinating Sensorimotor Neuropathy
1 clinical trial
1 product
Clinical trial
A Phase I Study of Lenalidomide in Combination With Dexamethasone in Anti-MAG Demyelinating Sensorimotor NeuropathyStatus: Terminated, Estimated PCD: 2022-02-28
Product
Lenalidomide